The application of metagenomic next-generation sequencing in diagnosing Chlamydia psittaci pneumonia: a report of five cases

Lei Gu,Wei Liu,Meng Ru,Jing Lin,Guoqing Yu,Jia Ye,Zheng-an Zhu,Yuebin Liu,Jian Chen,Guoxiang Lai,Wen Wen
DOI: https://doi.org/10.1186/s12890-020-1098-x
IF: 3.1
2020-03-17
BMC Pulmonary Medicine
Abstract:Abstract Background Chlamydia psittaci pneumonia is a zoonotic infectious disease caused by Chlamydia psittaci . Diagnostic tools, including culture, serologic test and PCR-based methods, are available but prone to false negative results. Case presentation This report included five cases of Chlamydia psittaci pneumonia. Symptoms and signs common to all 5 cases included fever, coughing, generalized muscle ache, and most notably, inflammatory infiltration of the lungs upon chest CT and X-ray. Metagenomic next-generation sequencing (mNGS) revealed the presence of Chlamydia psittaci in biopsy lung tissue in 3 cases and bronchoalveolar lavage fluid in the remaining 2 cases. Three patients responded to doxycycline plus moxifloxacin; two patients responded to moxifloxacin alone. Conclusions mNGS could be used to diagnose Chlamydia psittaci pneumonia.
respiratory system
What problem does this paper attempt to address?